Evaluation of the stability of tigecycline in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy
Tigecycline meets the UK YCD criteria of ≤5% degradation limit, indicating its suitability for both intermittent and continuous 24-h infusion in OPAT programs.
Authors
- Hayoung Won (ORCID: https://orcid.org/0000-0002-9248-5134)
- Jason A. Roberts (ORCID: https://orcid.org/0000-0001-6218-435X)
- R.A. Seaton (ORCID: https://orcid.org/0000-0002-2509-0597)
- Steven C. Wallis (ORCID: https://orcid.org/0000-0002-2392-9854)
- Fekade B. Sime (ORCID: https://orcid.org/0000-0003-4061-2063)
- Andrew Burke (ORCID: https://orcid.org/0000-0002-2742-1556)
- Sean Unwin
- Zenaw T Wolie
- Mary J.R. Gilchrist
Institutions
- Imperial College Healthcare NHS Trust (GB)
- The University of Queensland (AU)
- Université de Montpellier (FR)
- Royal Brisbane and Women's Hospital (AU)
- British Society for Antimicrobial Chemotherapy (GB)
- Metro South Health (AU)
- Infectious Diseases Institute (UG)
- Queen Elizabeth University Hospital (GB)
- Imperial College London (GB)
- Université de Nîmes (FR)
- Debre Markos University (ET)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1093/jacamr/dlaf074
- Citations
- 1
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- British Society for Antimicrobial Chemotherapy
- Medical Research Council
- National Health and Medical Research Council